•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Osisko Gold Royalties (TSE:OR) Stock Crosses Above 50 Day Moving Average – Time to Sell?
Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases
Osisko Gold: I Tried To Break The Bull Case, And I'm Still Buying
Is OR Royalties (OR) a Solid Growth Stock? 3 Reasons to Think "Yes"
OR Royalties Announces Preliminary Q3 2026 GEO Deliveries
Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilling at Cariboo Gold Project
Head-To-Head Contrast: USA Rare Earth (NASDAQ:USAR) and OR Royalties (NYSE:OR)
Osisko Gold Announces Management Update
Osisko Gold Completes US$600 Million Aggregate Principal Amount of 9.250% Senior Secured Notes Offering
OR Royalties Inc (OR) Stock Down 4.2% -- Now Undervalued? GF Score: 91/100
Osisko Gold Royalties (TSE:OR) Share Price Breaks Above 50-Day Moving Average – Should You Sell?
Asset Portfolio Briefing: First Gold Production at Cuiú Cuiú, Imminent Gold Production at Amulsar, and Other Positive Updates
Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project
Skip the Mine, Pocket the Gold: 5 Royalty Streamers Are Crushing Producers in 2026
Osisko Gold Royalties (TSE:OR) Stock Price Passes Above Fifty Day Moving Average – Here’s Why
Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026
Osisko Gold Announces CFO Transition to Support Its Next Stage of Growth
OR Royalties Q2 Earnings Call Highlights
OR Royalties Declares Third Quarter 2026 Dividend
OR Royalties Reports 62% Year-Over-Year Increase in Revenues and Cash Flows from Operations in Q2 2026 and Continued Share Repurchases Under the Normal Course Issuer Bid
Already premium?